Form D · Biotechnology
Trius Therapeutics Inc
San Diego, CA · CIK 0001356857
Offering snapshot reported Jun 7, 2011 · SEC filing
- Reported sold
- $30.2M Offering amount: $44.3M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 31, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 7, 2011 | Initial | $30,162,500 | No comparison | 25 | SEC filing |
| Nov 12, 2009 | Initial | $19,163,293 | No comparison | 11 | SEC filing |
| Apr 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 26, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 4, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 7, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.81M
- Finders' fees
- $0
- Form D file number
- 021-160869
Includes amounts receivable by the issuer upon the exercise of warrants to purchase the Issuer's securities, assuming no cashless exercise. Such Warrants have not yet been exercised.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Piper Jaffray & Co. | 665 |
Source: Form D, filed Jun 7, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian G. Atwood | Director |
| Kenneth Bartizal | Executive |
| Karin Eastham | Director |
| John Finn | Executive |
| David Kabakoff | Director |
| Nina Kjellson | Director |
| Michael Morneau | Executive |
| Brenden O'leary | Director |
| Michael Powell | Director |
| Philippe Prokocimer | Executive |
| John Schmid | Executive |
| Theodore R. Schroeder | Director |
| Risa Stack | Director |
| Jeffrey Stein | Director, Executive |
| Paul Truex | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6310 Nancy Ridge Drive, Suite 105
San Diego, CA, 92121
San Diego, CA, 92121